Pacific Biosciences of California (PACB) Competitors $1.80 +0.03 (+1.69%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PACB vs. QTRX, FLDM, HBIO, BLI, AXDX, TMO, A, MTD, WAT, and ILMNShould you be buying Pacific Biosciences of California stock or one of its competitors? The main competitors of Pacific Biosciences of California include Quanterix (QTRX), Fluidigm (FLDM), Harvard Bioscience (HBIO), Berkeley Lights (BLI), Accelerate Diagnostics (AXDX), Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), and Illumina (ILMN). Pacific Biosciences of California vs. Quanterix Fluidigm Harvard Bioscience Berkeley Lights Accelerate Diagnostics Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Quanterix (NASDAQ:QTRX) and Pacific Biosciences of California (NASDAQ:PACB) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment. Do analysts recommend QTRX or PACB? Quanterix currently has a consensus price target of $23.25, indicating a potential upside of 97.87%. Pacific Biosciences of California has a consensus price target of $3.63, indicating a potential upside of 101.39%. Given Pacific Biosciences of California's higher possible upside, analysts clearly believe Pacific Biosciences of California is more favorable than Quanterix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Quanterix 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Pacific Biosciences of California 0 Sell rating(s) 8 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.47 Which has more risk and volatility, QTRX or PACB? Quanterix has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, Pacific Biosciences of California has a beta of 2.01, meaning that its share price is 101% more volatile than the S&P 500. Is QTRX or PACB more profitable? Quanterix has a net margin of -30.71% compared to Pacific Biosciences of California's net margin of -227.69%. Quanterix's return on equity of -11.52% beat Pacific Biosciences of California's return on equity.Company Net Margins Return on Equity Return on Assets Quanterix-30.71% -11.52% -9.47% Pacific Biosciences of California -227.69%-42.71%-15.38% Does the MarketBeat Community prefer QTRX or PACB? Pacific Biosciences of California received 181 more outperform votes than Quanterix when rated by MarketBeat users. Likewise, 66.86% of users gave Pacific Biosciences of California an outperform vote while only 61.56% of users gave Quanterix an outperform vote. CompanyUnderperformOutperformQuanterixOutperform Votes26961.56% Underperform Votes16838.44% Pacific Biosciences of CaliforniaOutperform Votes45066.86% Underperform Votes22333.14% Which has stronger valuation and earnings, QTRX or PACB? Quanterix has higher earnings, but lower revenue than Pacific Biosciences of California. Quanterix is trading at a lower price-to-earnings ratio than Pacific Biosciences of California, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuanterix$122.37M3.69-$32.33M-$1.05-11.19Pacific Biosciences of California$200.52M2.46-$306.73M-$1.46-1.23 Does the media favor QTRX or PACB? In the previous week, Quanterix had 1 more articles in the media than Pacific Biosciences of California. MarketBeat recorded 9 mentions for Quanterix and 8 mentions for Pacific Biosciences of California. Quanterix's average media sentiment score of 0.03 beat Pacific Biosciences of California's score of -0.04 indicating that Quanterix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quanterix 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Pacific Biosciences of California 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in QTRX or PACB? 86.5% of Quanterix shares are owned by institutional investors. 6.9% of Quanterix shares are owned by company insiders. Comparatively, 2.4% of Pacific Biosciences of California shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. SummaryQuanterix beats Pacific Biosciences of California on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACB vs. The Competition Export to ExcelMetricPacific Biosciences of CaliforniaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$492.95M$5.46B$5.21B$8.85BDividend YieldN/A0.44%5.53%4.08%P/E Ratio-1.2312.3982.8815.55Price / Sales2.464.061,246.7687.28Price / CashN/A42.9440.9136.92Price / Book1.092.507.206.55Net Income-$306.73M$515,312.50$119.63M$226.22M7 Day Performance12.85%1.55%2.12%3.77%1 Month Performance2.86%-2.61%-2.43%4.64%1 Year Performance-78.47%-16.01%34.53%29.21% Pacific Biosciences of California Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACBPacific Biosciences of California1.365 of 5 stars$1.80+1.7%$3.63+101.4%-78.5%$492.95M$200.52M-1.23730QTRXQuanterix2.4117 of 5 stars$11.75+6.6%$23.25+97.9%-51.4%$450.97M$122.37M-11.23460News CoverageFLDMFluidigmN/AN/AN/AN/A$283.76M$130.58M-4.76615Analyst ForecastHBIOHarvard Bioscience1.5607 of 5 stars$2.16flatN/A-47.8%$94.21M$97.73M-6.55490Positive NewsHigh Trading VolumeBLIBerkeley Lights0.7847 of 5 starsN/AN/AN/A$72.04M$78.60M-0.70293AXDXAccelerate Diagnostics2.4584 of 5 stars$1.67-1.8%$1.00-40.1%-64.7%$41.82M$12.06M-0.58134Negative NewsTMOThermo Fisher Scientific4.9919 of 5 stars$515.26+0.5%$649.33+26.0%+5.3%$197.09B$42.86B32.30122,000Buyback AnnouncementPositive NewsAAgilent Technologies4.2492 of 5 stars$131.94+2.6%$144.36+9.4%+7.9%$37.91B$6.83B27.3718,100Upcoming EarningsDividend IncreaseNews CoverageMTDMettler-Toledo International3.6726 of 5 stars$1,195.00+2.4%$1,338.75+12.0%+12.9%$25.21B$3.79B32.2217,300Positive NewsWATWaters4.1844 of 5 stars$368.00+2.9%$365.85-0.6%+35.2%$21.85B$2.96B35.117,900ILMNIllumina4.5414 of 5 stars$137.09+4.1%$164.00+19.6%+43.4%$21.74B$4.50B-13.769,300 Related Companies and Tools Related Companies QTRX Competitors FLDM Competitors HBIO Competitors BLI Competitors AXDX Competitors TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PACB) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.